See editorial on pages 4–6, this issue.
Risk of colorectal cancer and adenomas in the families of patients with adenomas: A population-based study in Utah
Article first published online: 21 OCT 2013
© 2013 American Cancer Society
Volume 120, Issue 1, pages 35–42, 1 January 2014
How to Cite
Tuohy, T. M.F., Rowe, K. G., Mineau, G. P., Pimentel, R., Burt, R. W. and Samadder, N. J. (2014), Risk of colorectal cancer and adenomas in the families of patients with adenomas: A population-based study in Utah. Cancer, 120: 35–42. doi: 10.1002/cncr.28227
- Issue published online: 17 DEC 2013
- Article first published online: 21 OCT 2013
- Manuscript Accepted: 26 FEB 2013
- Manuscript Revised: 5 FEB 2013
- Manuscript Received: 17 OCT 2012
- colorectal cancer;
- adenomatous polyps;
Guidelines recommend that individuals with a first-degree relative (FDR) diagnosed with colorectal cancer (CRC) or advanced adenoma before age 60 years should undergo colonoscopy starting at age 40 years. The authors quantified the risk of adenomas and CRC in FDRs, second-degree relatives (SDRs), and third-degree relatives (TDRs) of patients diagnosed with adenomas and advanced adenomas.
A population-based, retrospective, case-control study was performed of residents of the state of Utah aged 50 years to 80 years who underwent colonoscopy between 1995 and 2009 at Intermountain Healthcare or the University of Utah. Controls were selected from the population of colonoscopy patients who were free of adenomas or CRC and matched to each case based on sex and birth year. Colonoscopy results were linked with cancer and pedigree information from the Utah Population Database to investigate the familial aggregation of adenomas and CRC using Cox regression analysis. The unit of analysis was the relatives of cases and controls.
Of 126,936 patients who underwent colonoscopy, 43,189 had adenomas and 5563 had advanced adenomas and defined the case population. An elevated risk of CRC was found in FDRs (relative risk [RR], 1.35; 95% confidence interval [95% CI], 1.25-1.46), SDRs (RR, 1.15; 95% CI, 1.07-1.23) of adenoma cases, and in FDRs of advanced adenoma cases (RR, 1.68; 95% CI, 1.29-2.18) compared with controls. Approximately 10% of CRCs diagnosed in relatives would have been missed if the current screening guidelines were strictly adhered to.
Relatives of colonoscopy patients with adenomas and advanced adenomas appear to have a significantly elevated risk of developing colorectal neoplasia. These data should be considered when establishing CRC screening guidelines for individuals and their families. Cancer 2014;120:35–42. © 2013 American Cancer Society.